About this trial
This is a prospective trial that attempts to develop evidence on the safety and performance of RA-TKA (Robotic-assisted total knee arthroplasty) with Skywalker and eMP (Evolution Medial Pivot) knee. Moreover to evaluate performance of eMP patients with Skywalker (in comparison to eMP with conventional instrumentations and non-MP TKAs)
Eligibility criteria
Qualifiers
>= 18 Years Male or Female
With noninflammatory degenerative joint disease, inflammatory joint disease, functional deformity
The subject has signed the Ethical Board approved Informed Consent Form specific to this study prior to enrollment
Must be independent, ambulatory, and can comply with all post-operative evaluations and visits.
Disqualifiers
Subjects with poor compliance, unable to complete the trial according to the requirements or for other reasons or considered not to be suitable for inclusion by investigators.
Concurrent participation in any other total hip or knee replacement studies.
Trial design
Treatments tested in this trial
- Robotic TKA
- Conventional TKA
Treatment groups
Sponsors and collaborators
Orthopaedic Department of General University Hospital of Laria
Lead sponsor
MicroPort Orthopedics Inc.
Collaborator